eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

  Tools   Community
All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms       Ask question       Write review       Answered/ Unanswered       Reviews       WellConnected

From FDA reports: drug interactions between Copaxone, Cipro, Amantadine, Reglan for a Female patient aged 33

This is a personalized study for a 33 year old female patient. The study is created by eHealthMe based on reports of 7 people who take the same drugs and have drug interactionsfrom FDA.

On Oct, 31, 2014: 7 people who reported to have interactions when taking Copaxone, Cipro, Amantadine, Reglan are studied

Trend of Copaxone, Cipro, Amantadine, Reglan's drug interactions, side effects, and effectiveness reports (1738607)

Information of the patient in this study:

Age: 33

Gender: female

Drugs taking:
- Copaxone
- Cipro
- Amantadine
- Reglan

Drug interactions have: Dermatitis Nos, Difficulty In Walking, Injection Site Cyst, Injection Site Pain, Multiple Sclerosis Aggravated, Pruritus

eHealthMe real world results:

Comparison with this patient's adverse outcomes among females aged 33 (±5):

InteractionNumber of reports
Dermatitis Nos2 (100.00%)
Difficulty In Walking2 (100.00%)
Injection Site Cyst2 (100.00%)
Injection Site Pain2 (100.00%)
Multiple Sclerosis Aggravated (worse a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)2 (100.00%)
Pruritus (severe itching of the skin)2 (100.00%)

Most common interactions experienced by females aged 33 (±5) in the use of Copaxone, Cipro, Amantadine, Reglan:

InteractionNumber of reports
Multiple Sclerosis Aggravated (worse a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)2
Pruritus (severe itching of the skin)2
Difficulty In Walking2
Injection Site Pain2
Dermatitis Nos2
Peroneal Nerve Palsy (dysfunction of nerve controlling movement and sensation to the lower leg, foot and toes)2
Urinary Tract Infection Nos2
Pituitary Tumour Benign Nos2
Prolactinoma (benign tumour (adenoma) of the pituitary gland that produces a hormone called prolactin)2
Urinary Frequency2

Most common interactions experienced by females aged 33 (±5) in long term use of Copaxone, Cipro, Amantadine, Reglan:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Dermatitis Nos4 (57.14%)
Difficulty In Walking4 (57.14%)
Injection Site Cyst2 (28.57%)
Injection Site Pain4 (57.14%)
Multiple Sclerosis Aggravated (worse a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)4 (57.14%)
Pruritus (severe itching of the skin)4 (57.14%)

Most common interactions experienced by people in the use of Copaxone, Cipro, Amantadine, Reglan:

InteractionNumber of reports
Injection Site Pain4
Multiple Sclerosis Aggravated (worse a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)4
Difficulty In Walking4
Chest Pain4
Pruritus (severe itching of the skin)4
Injection Site Inflammation4
Dermatitis Nos4
Injection Site Reaction Nos4
Depression Nec (depression not elsewhere classified)4
Myasthenic Syndrome (a group of conditions characterized by muscle weakness (myasthenia) that worsens with physical exertion)2

Most common interactions experienced by people in long term use of Copaxone, Cipro, Amantadine, Reglan:

None.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.